Description:
Rompag is a thrombopoietin receptor agonist developed to boost platelet counts in patients suffering from chronic immune thrombocytopenia (ITP), aplastic anemia, and hepatitis C-related thrombocytopenia. It mimics the natural thrombopoietin hormone to stimulate the bone marrow and promote platelet production.
Rompag helps reduce the frequency of bleeding episodes and minimizes the need for platelet transfusions, offering patients a more stable and sustained recovery. With its oral administration and proven clinical outcomes, Rompag plays a pivotal role in managing chronic platelet deficiency disorders.
Share your experience with our medical product. Write a review!
20 Jan 2026
PCOS Symptoms and Management: Signs Most Women Overlook
Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.
24 Dec 2025
Patch vs Pills: Why Transdermal Patches Are the Modern Choice for Pain & Wellness
(A Deep Dive into Pain Relief Patches, Wellness Patches & Modern Drug Delivery Technology)
16 Dec 2025
Top 7 Everyday Foods That Trigger Acidity - And How Jeerafast Helps You Enjoy Meals Without the Burn
(A complete Indian-friendly guide for digestion, bloating, acidity, and natural relief)
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
